TGENHIGH SIGNALFINANCIAL10-K

Tecogen's operating losses substantially expanded despite revenue growth, while the company significantly reduced capital expenditures and improved its balance sheet liquidity position.

The dramatic deterioration in operating performance despite nearly 20% revenue growth suggests serious operational inefficiencies or cost structure problems that management needs to address urgently. However, the substantial improvement in working capital and reduction in liabilities indicates the company may be actively managing cash flow and debt obligations during this challenging period.

Comparing 2026-03-19 vs 2025-03-18View on EDGAR →
FINANCIAL ANALYSIS

Tecogen showed mixed financial results with revenue growing modestly to $27.1M, but operating losses expanding substantially to -$8.2M, indicating severe margin compression. The balance sheet strengthened considerably with current assets increasing 30% to $28.9M while current liabilities fell 45% to $9.3M, significantly improving liquidity. The company also reduced capital expenditures by nearly 60% to $401K, suggesting either completion of prior investment cycles or cash preservation measures.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-81.8%
-$4.5M→-$8.2M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Net Income
P&L
-73.3%
-$4.8M→-$8.2M

Net income declined 73.3% — review whether driven by operations, interest costs, or non-recurring items.

Capital Expenditure
Cash Flow
-58.6%
$969K→$401K

Capex reduced 58.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Current Liabilities
Balance Sheet
-44.9%
$16.8M→$9.3M

Current liabilities reduced — improved short-term financial position and working capital health.

Current Assets
Balance Sheet
+30.4%
$22.1M→$28.9M

Current assets grew 30.4% — improving short-term liquidity or inventory/receivables build.

Accounts Receivable
Balance Sheet
-29%
$6.0M→$4.3M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Total Liabilities
Balance Sheet
-26%
$21.0M→$15.5M

Liabilities reduced 26% — deleveraging improves balance sheet strength and financial flexibility.

R&D Expense
P&L
+21.3%
$962K→$1.2M

R&D investment increased 21.3% — signals commitment to future product development, though near-term margin impact.

Revenue
P&L
+19.7%
$22.6M→$27.1M

Revenue growing 19.7% — solid top-line momentum, watch margins for quality of growth.

Total Assets
Balance Sheet
+19%
$31.1M→$37.0M

Asset base grew 19% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-03-19
PRIOR — 2025-03-18
ADDED
As of March 19, 2026, 29,855,229 shares of common stock, $.001 par value per share, of the registrant were issued and outstanding.
Such forward-looking statements include, among other things, demand for our products and services, the availability of incentives, rebates, and tax benefits relating to our products, changes in the regulatory environment relating to our products, competing technological developments, and the availability of financing to fund our operations and growth.
Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements.
Management's Discussion and Analysis of Financial Condition and Results of Operations" in this report, as well as other sections in this report that discuss some of the factors that could contribute to these differences.
References in this report to "we," "our," "us," the "Company" and "Tecogen" refer to Tecogen Inc.
+7 more — sign up free →
REMOVED
As of March 18, 2025, 24,985,261 shares of common stock, $.001 par value per share, of the registrant were issued and outstanding.
Risk Factors," "Item 7.Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Item 1.
Business, " as well as other sections in this report that discuss some of the factors that could contribute to these differences.
(together with its subsidiaries, we, our, or us, or Tecogen ) designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products including natural gas engine driven combined heat and power, chillers, air conditioning systems, and water heaters for multi-family residential, commercial, recreational and industrial use.
We provide cost efficient, environmentally friendly and reliable products for distributed power generation that deliver substantial energy savings, resiliency from utility power outages, and nearly eliminate criteria pollutants including nitrogen oxide ("NOx") and carbon monoxide ("CO"), significantly reducing customers' carbon footprint.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →